Literature DB >> 16971425

Requirements for the assembly and release of Newcastle disease virus-like particles.

Homer D Pantua1, Lori W McGinnes, Mark E Peeples, Trudy G Morrison.   

Abstract

Paramyxoviruses, such as Newcastle disease virus (NDV), assemble in and bud from plasma membranes of infected cells. To explore the role of each of the NDV structural proteins in virion assembly and release, virus-like particles (VLPs) released from avian cells expressing all possible combinations of the nucleoprotein (NP), membrane or matrix protein (M), an uncleaved fusion protein (F-K115Q), and hemagglutinin-neuraminidase (HN) protein were characterized for densities, protein content, and efficiencies of release. Coexpression of all four proteins resulted in the release of VLPs with densities and efficiencies of release (1.18 to 1.16 g/cm(3) and 83.8% +/- 1.1%, respectively) similar to those of authentic virions. Expression of M protein alone, but not NP, F-K115Q, or HN protein individually, resulted in efficient VLP release, and expression of all different combinations of proteins in the absence of M protein did not result in particle release. Expression of any combination of proteins that included M protein yielded VLPs, although with different densities and efficiencies of release. To address the roles of NP, F, and HN proteins in VLP assembly, the interactions of proteins in VLPs formed with different combinations of viral proteins were characterized by coimmunoprecipitation. The colocalization of M protein with cell surface F and HN proteins in cells expressing all combinations of viral proteins was characterized. Taken together, the results show that M protein is necessary and sufficient for NDV budding. Furthermore, they suggest that M-HN and M-NP interactions are responsible for incorporation of HN and NP proteins into VLPs and that F protein is incorporated indirectly due to interactions with NP and HN protein.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16971425      PMCID: PMC1642154          DOI: 10.1128/JVI.00726-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

1.  Expression vector system based on the chicken beta-actin promoter directs efficient production of interleukin-5.

Authors:  J Miyazaki; S Takaki; K Araki; F Tashiro; A Tominaga; K Takatsu; K Yamamura
Journal:  Gene       Date:  1989-07-15       Impact factor: 3.688

2.  A morphological study of the M-protein of Sendai virus.

Authors:  J A Hewitt; M V Nermut
Journal:  J Gen Virol       Date:  1977-01       Impact factor: 3.891

3.  Efficient selection for high-expression transfectants with a novel eukaryotic vector.

Authors:  H Niwa; K Yamamura; J Miyazaki
Journal:  Gene       Date:  1991-12-15       Impact factor: 3.688

4.  Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells.

Authors:  D Gheysen; E Jacobs; F de Foresta; C Thiriart; M Francotte; D Thines; M De Wilde
Journal:  Cell       Date:  1989-10-06       Impact factor: 41.582

5.  Radiation studies of avian tumor viruses and of Newcastle disease virus.

Authors:  W Levinson; H Rubin
Journal:  Virology       Date:  1966-04       Impact factor: 3.616

6.  Sendai virus M protein binds independently to either the F or the HN glycoprotein in vivo.

Authors:  C M Sanderson; H H Wu; D P Nayak
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

7.  The Sendai virus matrix protein appears to be recruited in the cytoplasm by the viral nucleocapsid to function in viral assembly and budding.

Authors:  R Stricker; G Mottet; L Roux
Journal:  J Gen Virol       Date:  1994-05       Impact factor: 3.891

8.  Strain variation and nuclear association of Newcastle disease virus matrix protein.

Authors:  K S Faaberg; M E Peeples
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

9.  Viral liposomes released from insect cells infected with recombinant baculovirus expressing the matrix protein of vesicular stomatitis virus.

Authors:  Y Li; L Luo; M Schubert; R R Wagner; C Y Kang
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

10.  The GAG precursor of simian immunodeficiency virus assembles into virus-like particles.

Authors:  M Delchambre; D Gheysen; D Thines; C Thiriart; E Jacobs; E Verdin; M Horth; A Burny; F Bex
Journal:  EMBO J       Date:  1989-09       Impact factor: 11.598

View more
  84 in total

1.  Structure and assembly of a paramyxovirus matrix protein.

Authors:  Anthony J Battisti; Geng Meng; Dennis C Winkler; Lori W McGinnes; Pavel Plevka; Alasdair C Steven; Trudy G Morrison; Michael G Rossmann
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-13       Impact factor: 11.205

2.  Murine immune responses to virus-like particle-associated pre- and postfusion forms of the respiratory syncytial virus F protein.

Authors:  Lori McGinnes Cullen; Madelyn R Schmidt; Sarah A Kenward; Robert T Woodland; Trudy G Morrison
Journal:  J Virol       Date:  2015-04-22       Impact factor: 5.103

3.  Interaction of Human Parainfluenza Virus Type 3 Nucleoprotein with Matrix Protein Mediates Internal Viral Protein Assembly.

Authors:  Guangyuan Zhang; Yi Zhong; Yali Qin; Mingzhou Chen
Journal:  J Virol       Date:  2015-12-09       Impact factor: 5.103

4.  Viral protein determinants of Lassa virus entry and release from polarized epithelial cells.

Authors:  Katrin Schlie; Anna Maisa; Fabian Freiberg; Allison Groseth; Thomas Strecker; Wolfgang Garten
Journal:  J Virol       Date:  2010-01-13       Impact factor: 5.103

5.  Structural analysis of respiratory syncytial virus reveals the position of M2-1 between the matrix protein and the ribonucleoprotein complex.

Authors:  Gabriella Kiss; Jens M Holl; Grant M Williams; Eric Alonas; Daryll Vanover; Aaron W Lifland; Manasa Gudheti; Ricardo C Guerrero-Ferreira; Vinod Nair; Hong Yi; Barney S Graham; Philip J Santangelo; Elizabeth R Wright
Journal:  J Virol       Date:  2014-04-23       Impact factor: 5.103

6.  Virus-like particle vaccine confers protection against a lethal newcastle disease virus challenge in chickens and allows a strategy of differentiating infected from vaccinated animals.

Authors:  Jae-Keun Park; Dong-Hun Lee; Seong-Su Yuk; Erdene-Ochir Tseren-Ochir; Jung-Hoon Kwon; Jin-Yong Noh; Byoung-Yoon Kim; Soo-Won Choi; Sang-Moo Kang; Joong-Bok Lee; Seung-Yong Park; In-Soo Choi; Chang-Seon Song
Journal:  Clin Vaccine Immunol       Date:  2014-01-08

7.  Solution Structure, Self-Assembly, and Membrane Interactions of the Matrix Protein from Newcastle Disease Virus at Neutral and Acidic pH.

Authors:  E V Shtykova; M V Petoukhov; L A Dadinova; N V Fedorova; V Yu Tashkin; T A Timofeeva; A L Ksenofontov; N A Loshkarev; L A Baratova; C M Jeffries; D I Svergun; O V Batishchev
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

8.  Genetic comparisons between lentogenic Newcastle disease virus isolated from waterfowl and velogenic variants.

Authors:  Ryota Tsunekuni; Hiroshi Ito; Koichi Otsuki; Hiroshi Kida; Toshihiro Ito
Journal:  Virus Genes       Date:  2009-12-12       Impact factor: 2.332

9.  Chapter 4 - Reconstitution of membrane budding with unilamellar vesicles.

Authors:  Anna V Shnyrova; Joshua Zimmerberg
Journal:  Methods Enzymol       Date:  2009       Impact factor: 1.600

10.  Newcastle disease virus-like particles containing respiratory syncytial virus G protein induced protection in BALB/c mice, with no evidence of immunopathology.

Authors:  Matthew R Murawski; Lori W McGinnes; Robert W Finberg; Evelyn A Kurt-Jones; Michael J Massare; Gale Smith; Penny M Heaton; Armando E Fraire; Trudy G Morrison
Journal:  J Virol       Date:  2009-11-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.